Page last updated: 2024-09-02

tadalafil and mebendazole

tadalafil has been researched along with mebendazole in 3 studies

Compound Research Comparison

Studies (tadalafil)	Trials (tadalafil)	Recent Studies (post-2010) (tadalafil)	Studies (mebendazole)	Trials (mebendazole)	Recent Studies (post-2010) (mebendazole)
1,742	392	1,089	2,089	184	438

Protein Interaction Comparison

Protein	Taxonomy	mebendazole (IC50)
Tyrosine-protein kinase ABL1	Homo sapiens (human)	5
Vascular endothelial growth factor receptor 2	Homo sapiens (human)	5.5667
Calmodulin-domain protein kinase 1	Toxoplasma gondii	0.67

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Grohganz, H; Knuhtsen, A; Löbmann, K; Pedersen, DS; Rades, T; Schnitzkewitz, J; Wu, W	1

Reviews

1 review(s) available for tadalafil and mebendazole

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

2 other study(ies) available for tadalafil and mebendazole

Article	Year
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Aspartame as a co-former in co-amorphous systems. International journal of pharmaceutics, 2018, Oct-05, Volume: 549, Issue:1-2 Topics: Aspartame; Crystallization; Drug Compounding; Drug Stability; Excipients; Feasibility Studies; Mebendazole; Piroxicam; Powders; Solubility; Tadalafil; Technology, Pharmaceutical; Time Factors; Transition Temperature; Vitrification	2018

Article

Year

A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.

Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013

Aspartame as a co-former in co-amorphous systems.

International journal of pharmaceutics, 2018, Oct-05, Volume: 549, Issue:1-2

Topics: Aspartame; Crystallization; Drug Compounding; Drug Stability; Excipients; Feasibility Studies; Mebendazole; Piroxicam; Powders; Solubility; Tadalafil; Technology, Pharmaceutical; Time Factors; Transition Temperature; Vitrification

2018